Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.32B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$2.19B |
| 3 |
Apple
AAPL
|
+$2.17B |
| 4 |
NVIDIA
NVDA
|
+$2.12B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$563M |
| 2 |
Jefferies Financial Group
JEF
|
+$510M |
| 3 |
SPDR Gold Trust
GLD
|
+$313M |
| 4 |
S&P Global
SPGI
|
+$286M |
| 5 |
CrowdStrike
CRWD
|
+$196M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.69% |
| 2 | Consumer Discretionary | 7.38% |
| 3 | Financials | 7.04% |
| 4 | Healthcare | 5.93% |
| 5 | Communication Services | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
STAAR Surgical
STAA
$1.21B
| $1.21M | ﹤0.01% |
68,882
-211
| -0.3% | -$4.23K |
|
3027
Appian
APPN
$1.94B
| $1.21M | ﹤0.01% |
42,097
-5,252
| -11% | -$172K |
|
|
AGNT
3028
AGNT Inc
AGNT
$641M
| $1.21M | ﹤0.01% |
123,636
+8,427
| +7% | +$89.5K |
|
3029
Asana
ASAN
$1.83B
| $1.21M | ﹤0.01% |
82,988
-2,468
| -3% | -$46.8K |
|
|
AVDX
3030
DELISTED
AvidXchange
AVDX
| $1.2M | ﹤0.01% |
142,068
-36,267
| -20% | -$335K |
|
3031
PC Connection
CNXN
$2.08B
| $1.2M | ﹤0.01% |
19,272
+2,128
| +12% | +$141K |
|
3032
PUT
Biohaven
BHVN
$2.08B
| $1.2M | ﹤0.01% |
+50,000
| New | +$1.76M |
|
3033
Sturm, Ruger & Co
RGR
$623M
| $1.2M | ﹤0.01% |
30,529
+1,661
| +6% | +$62.4K |
|
3034
Marcus & Millichap
MMI
$1.18B
| $1.2M | ﹤0.01% |
34,807
-256
| -0.7% | -$9.43K |
|
3035
ARS Pharmaceuticals
SPRY
$559M
| $1.2M | ﹤0.01% |
95,210
-5,473
| -5% | -$65.8K |
|
3036
Cadre Holdings
CDRE
$1.31B
| $1.2M | ﹤0.01% |
40,441
-294
| -0.7% | -$10.1K |
|
3037
iShares Morningstar Mid-Cap Growth ETF
IMCG
$3.93B
| $1.2M | ﹤0.01% |
16,739
-1,131
| -6% | -$86.2K |
|
3038
CALL
New Oriental
EDU
$9B
| $1.2M | ﹤0.01% |
25,000
| – | – |
|
3039
Dimensional US High Profitability ETF
DUHP
$12.3B
| $1.19M | ﹤0.01% |
35,960
+5,660
| +19% | +$194K |
|
|
WSR
3040
DELISTED
Whitestone REIT
WSR
| $1.19M | ﹤0.01% |
81,697
-1,865
| -2% | -$25.7K |
|
3041
NVE Corp
NVEC
$555M
| $1.19M | ﹤0.01% |
18,667
+2,254
| +14% | +$162K |
|
3042
iShares Core Universal USD Bond ETF
IUSB
$43B
| $1.19M | ﹤0.01% |
25,798
-9,537
| -27% | -$435K |
|
3043
PUT
Webster Financial
WBS
$12.5B
| $1.19M | ﹤0.01% |
+23,000
| New | +$1.28M |
|
3044
Howard Hughes
HHH
$3.87B
| $1.18M | ﹤0.01% |
15,993
-59,935
| -79% | -$4.52M |
|
3045
Cogent Biosciences
COGT
$7.07B
| $1.18M | ﹤0.01% |
197,007
+52,553
| +36% | +$412K |
|
|
LADR
3046
Ladder Capital
LADR
$1.23B
| $1.18M | ﹤0.01% |
103,283
-7,694
| -7% | -$87.9K |
|
3047
DHT Holdings
DHT
$2.99B
| $1.18M | ﹤0.01% |
112,006
-6,547
| -6% | -$70.5K |
|
3048
First Trust Cloud Computing ETF
SKYY
$2.86B
| $1.17M | ﹤0.01% |
11,467
+3
| +0% | +$357 |
|
3049
CALL
MoonLake Immunotherapeutics
MLTX
$1.62B
| $1.17M | ﹤0.01% |
30,000
+5,000
| +20% | +$215K |
|
|
3050
PUT
MoonLake Immunotherapeutics
MLTX
$1.62B
| $1.17M | ﹤0.01% |
30,000
+5,000
| +20% | +$215K |
|
Similar funds
Citigroup's Q1 2025 Portfolio in Review
As of Q1 2025, Citigroup held 6,124 positions worth $196B, up 16% from $169B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup deployed $38.1B of net new capital in Q1 2025, opening 294 new positions and adding to 2,193 existing holdings. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 2,013,956 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares China Large-Cap ETF, an estimated $563M trimmed.
- Citigroup's largest Q1 2025 buy was Boeing Co 6.00% Series A Preferred Stock: 2,013,956 shares worth $120M.
- Citigroup added most to Microsoft in Q1 2025, an estimated $2.32B increase.
- Citigroup's biggest Q1 2025 reduction was iShares China Large-Cap ETF, cutting an estimated $563M.
- Citigroup fully exited Retail Opportunity Investments Corp. in Q1 2025, selling an estimated $46.9M.
- Citigroup's ten largest holdings make up 24% of its $196B portfolio in Q1 2025.
- Citigroup opened 294 new positions and closed 585 in Q1 2025.
- Citigroup's portfolio value rose 16% quarter-over-quarter to $196B.
Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.